In recognition of March being Colorectal Cancer Awareness Month, CRHC is highlighting the the partnership with Colorado Cancer Screening Program (CCSP) of the University of Colorado which aims to identify and correct the causes of low screening rates

New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study indicates.

The American Cancer Society (ACS) has partnered with hospitals and imaging facilities across Delaware to present National Lung Cancer Screening Day (NLCSD) as a statewide event. On Saturday, November 11, representatives from the Bureau of Cancer Prevention and Control within the Delaware Division of Public Health (DPH) will be on-site at several imaging facilities. Delaware is the […]

The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT), American College of Radiology® (ACR®), Radiology Health Equity Coalition (RHEC), and GO2 for Lung Cancer (GO2) have partnered once again for the second annual National Lung Cancer Screening Day (“National LCS Day”) on Saturday, November 9, 2024, which has been officially proclaimed by Governor John […]

Purpose:

Colorectal cancer (CRC) screening is recommended starting at age 45, but there has been little research on strategies to promote screening among patients younger than 50. This study assessed the effect of a multicomponent intervention on screening completion in this age group.

The Indian Council of Medical Research─National Institute of Cancer Prevention and Research (ICMR─NICPR) is set to launch its first─ever DHR─funded National NICPR─ECHO online certificate course on cervical

A Sydney university has unveiled a new program to enhance cervical cancer screening and treatment in the South Pacific (!--ref1--). The University

To give better access to women for screening of cancer, the Health Department is taking their programmes to work sites and also encouraging women to come in for annual check-ups

In the three-level screening, ASHAs and ANMs will visit houses and conduct initial tests; those with symptoms will be sent to village health clinics for examination by a medical officer, who will refer patients in need of more tests to medical colleges

Cervical screening programmes in many countries stop at around the age of 65 and much of the focus is often on younger women. However, comparatively little attention has been given to older women despite the fact that they account for about a fifth of cases each year and half of deaths. In this podcast Susan Sherman, a senior lecturer in...

The claim that cancer screening saves lives is based on fewer deaths due to the target cancer. Vinay Prasad, assistant professor at Oregon Health and Science University, joins us to argue that reductions in overall mortality should be the benchmark and call for higher standards of evidence for cancer screening. Read the full...

Title: HPV Test Beats Pap Smear for Cancer Screening
Category: Health News
Created: 4/28/2010 12:10:00 PM
Last Editorial Review: 4/29/2010 12:00:00 AM

Cancer continues to be one of the leading causes of morbidity and mortality in the US. Although the treatment of cancer has evolved over the past decades with the use of targeted therapies and immunotherapy, many of these new treatments are expensive and are not readily available to everyone. Moreover, the recent success with treatment advances are not generalized to all cancer types, as some cancers continue to be devastating without significant progress in treatment options. Hence, early detection through population screening remains a critical armament against cancer.

Background:

Total antioxidant capacity (TAC) reflects an individual's overall antioxidant intake. We sought to clarify whether higher TAC is associated with lower risks of pancreatic cancer incidence and mortality in the U.S. general population.

New study guides clinicians on managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. The findings of the

Use of some cancer screening and monitoring tests came to 'a near standstill' in early April in the US, a new report indicates.
Medscape Medical News

Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model

Interview with Daniel Scott. Reuland, MD MPH, author of Evaluating Shared Decision Making for Lung Cancer Screening, and Bruno Heleno, MD, PhD, author of Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening

Interview with George F. Sawaya, MD, author of Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis, and Sarah Feldman, M.D. M.P.H., author of Screening Options for Preventing Cervical Cancer

Interview with Kari A O Tikkinen, MD, PhD, author of Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis

Interview with Melinda C. Aldrich, author of Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers

Interview with Caroline A. Nelson, MD, author of Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study

Interview with Pim A. de Jong, MD, PhD, author of Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans

Interview with Roger Chou, MD, author of Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications

Interview with Nancy L. Keating, MD, MPH, author of A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions

Interview with Sarah M. Friedewald, MD, author of Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography

Interview with Chyke A. Doubeni, MD, MPH, author of Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model

Interview with Kevin C. Oeffinger, MD, author of Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society

Interview with Elizabeth T. H. Fontham, MPH, DrPH, author of Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society, Nancy L. Keating, MD, MPH, author of New Guidelines for Breast Cancer Screening in US Women, and Evan R. Myers, MD, MPH, author of Benefits and Harms of Breast Cancer Screening: A Systematic Review

Edward H. Livingston, MD, Deputy Editor of Clinical Reviews and Education and Jon Tilburt, MD, from the Mayo Clinic explain prostate cancer screening. For more information, read the JAMA Patient Page on this topic.

Edward H. Livingston MD, explores the topic of prostate cancer screening in author interviews with:

• Dan Merenstein about losing a malpractice case despite following evidence-based medicine guidelines (PSA Screening — I Finally Won!).
• Otis Brawley about Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
• David F. Penson about The Pendulum of Prostate Cancer Screening.
• Victor M. Montori about The Connection Between Evidence-Based Medicine and Shared Decision Making.